The complete guide to safety in the dental clinic: imaging radiation protection and infection control

The complete guide to safety in the dental clinic: imaging radiation protection and infection control

TL;DR

Dental imaging doses are counted in microsieverts [Fn9]; whether an image is taken at all is decided case by case on clinical indication [Fn4]; the floor of infection control is standard precautions, which apply alike to every patient [Fn48].

(51 characters in the zh-Hant original, [Fn] markers not counted)

Introduction

This article is general oral-health education based on international literature. It does not address any country's insurance or regulations; consult local rules for care pathways and costs.

“Is this clinic safe?” is a question a patient sitting in the chair can almost never answer for themselves. You cannot see what happens inside the autoclave, you cannot see the inner wall of the few metres of tubing behind the dental chair, and you have no way of sensing what the radiograph you have just had means for your body. So the topic grows into two extremes online: one that talks about dental X-rays as carrying no risk, and one that talks about them as definitely causing cancer; one that says instruments “are all disinfected”, and one that says “dental tubing is filthy”.

This article takes neither side. It does something more useful: it breaks in-clinic safety down into two chains that are independent of each other, and sets out what each link is required to do under professional standards, how far the evidence goes, and which statements the literature at present simply cannot make.

Two things need to be stated first, because they govern how every later section should be read:

First, this is a map of the field, not an appraisal of any clinic. This article does not evaluate, compare or recommend any healthcare institution or dentist, and it provides no checklist that could be used to judge whether a given clinic passes muster. What the literature can give is “what professional standards require”, not “whether the clinic in front of you has met them”.

Second, “contamination is widespread” and “infection is common” are two different things. This distinction recurs throughout the infection-control sections. What studies measure is mostly the proportion of microorganisms present in the environment, not the proportion of patients actually infected; several layers of dose, pathogenicity, host susceptibility and protective measures lie between the two. Reading the former straight off as the latter is the misreading this field is most prone to, and the one most likely to cause needless anxiety.

1. Splitting “in-clinic safety” into two chains

In the literature, safety in the dental clinic is really two almost unrelated professional systems that happen to take place beside the same chair.

The key to this table is the last row: the two chains have different forms of evidence, so what can be said about each differs too. The imaging chain can give magnitudes in microsieverts [Fn9][Fn10][Fn11]; the infection-control chain can give “what proportion is detected in the environment” and “what proportion of personnel are injured” [Fn74][Fn103], not “the probability that a patient is infected”. That difference determines how far each sentence in this article can go.

2. Imaging chain, part one: four classes of dental imaging and the dose-reducing measures for each

Dental imaging is not one thing. The systematic review cited here divides it into several classes and gives protective measures for each, while professional guidance places them all within a single decision framework [Fn3][Fn4].

A retrieval limit first: the source texts retrievable for this article (the title and abstract of each paper) do not set out, item by item, the clinical indications for each class of imaging, CBCT excepted. This section therefore does not state what periapical, bitewing and panoramic radiographs are each “used to look at” — that would require full-text-level content, and this article adds nothing for which it has no source. Which type of imaging any individual diagnosis requires is decided by the dentist on clinical examination [Fn4].

• Periapical radiographs: an intraoral image. The dose-reducing measures for this class are summarised in the systematic review as rectangular collimation, a faster image receptor speed, and thyroid shielding when the thyroid gland is in line of or very close to the primary beam [Fn37].
• Bitewing radiographs: also intraoral, and the same set of dose-reducing measures applies [Fn37].
• Panoramic radiographs: the systematic review summarises the dose-reducing measures as collimation, a faster receptor type, and the use of automatic exposure control or manual adjustment of intensity [Fn38].
• Cone-beam computed tomography (CBCT): a systematic review focused on implant dentistry records that the indications for CBCT in implant dentistry run from preoperative assessment of anatomical structures, through planning of site reconstruction with bone grafting and computer-aided treatment planning, to assessment of postoperative complications [Fn18]. Guidance from the same body explicitly requires that all imaging modalities, CBCT included, be used judiciously in order to reduce the patient's cumulative radiation exposure [Fn3].

⚠ The above is a summary from the literature of the protective measures for each class of imaging; it does not constitute a recommendation that any individual patient should have any particular image taken. Image interpretation in endodontic diagnosis is covered in domain article P03; the imaging considerations in assessing wisdom teeth are covered in domain article P06.

3. Imaging chain, part two: the scale of magnitude for dose

3-1 The magnitudes that can currently be cited

“How much radiation is there in a dental X-ray?” is a question that can be answered honestly only as an order of magnitude, not as a single figure.

A review that compiled organ and effective doses for dental imaging from the literature published between 2010 and 2020 [Fn15] reports the following mean effective doses and their ranges:

The same review records two further variables that alter dose: in CBCT images, child phantoms received about 29% more effective dose than adult phantoms [Fn13]; and the effective dose of a large field of view (>150 cm²) was about 1.6 times that of a small field of view (<50 cm²) [Fn14].

⚠ The background-radiation comparison value at the foot of the table comes from the same review [Fn12], and the original does not state the geographical or population basis on which that average rests; this article uses it only to convey a sense of magnitude, makes no cross-regional comparison, and derives from it no conversion of the form “equivalent to N radiographs”.

How to read this table correctly: the ranges in brackets are the point. The dose from the same examination can differ several-fold between machines and between settings, so any single statement of the form “a dental X-ray equals N microsieverts” has dropped the range. These values come from a compilation of the literature rather than from a single standardised measurement [Fn15], and they include results from phantom simulation — the original itself presents part of its data as a comparison between child and adult phantoms [Fn13]; as for what proportion is phantom simulation and what proportion is measurement in real people, the abstract layer does not say, and this article makes no estimate. Their use is therefore to provide a reference magnitude, not to predict the dose that any individual patient actually receives.

3-2 Why no single figure can be given for CBCT

The spread of CBCT doses has been pointed out independently in the literature [Fn16]. One systematic review records that the effective doses of different CBCT devices span a very wide range, the dose at the lower end of the interval being almost one-hundredth of that at the upper end [Fn16]; and it notes that adjusting the operating parameters (including exposure factors) and reducing the field of view to the actual region of interest can achieve significant dose reduction [Fn17].

Read [Fn16] together with [Fn11] and the conclusion is consistent: the dose from CBCT is a variable that can be adjusted, determined by device and settings, not a constant fixed at the factory. This is also why professional guidance singles CBCT out and requires that it be used judiciously [Fn3].

3-3 Two common misreadings

Misreading one: taking the mean for the ceiling. The CBCT mean in the table is 121.09 μSv, but the upper end of the range in the same dataset is 392.20 μSv [Fn11]. Citing the mean while dropping the range systematically understates the spread.

Misreading two: taking the background-radiation comparison to mean “so there is no effect”. The dose review does provide a comparison figure of 3110 μSv per person per year from natural background radiation [Fn12], but the function of that comparison is to convey a sense of magnitude, not to prove that the biological effect is zero — the latter belongs to section 4, and the two cannot substitute for each other.

4. Imaging chain, part three: the risk evidence has to be read on two levels

On the question of whether dental X-rays are harmful, the current literature reaches conclusions at two different levels, and the directions look opposite [Fn19][Fn24][Fn26]. They must be read as layers; neither may be taken on its own.

4-1 The population epidemiology level: the association signal exists, but causation is not established

A 2026 systematic review and meta-analysis screened 1,883 records and included 24 studies, of which 19 entered the meta-analysis, covering 415,887 participants [Fn20]. The results:

• in 16 case-control studies, thyroid cancer was significantly associated with dental imaging (OR = 2.21; 95% CI 1.63–2.99) [Fn21];
• also in case-control studies, central nervous system tumours showed a non-significant elevation (OR = 1.31; 95% CI 0.89–1.91) [Fn22];
• in 3 cohort studies, thyroid cancer showed a small but significant association with conventional radiography (HR = 1.13; 95% CI 1.01–1.26) [Fn25];
• also in cohort studies, the risk of central nervous system tumours was moderately associated with CT exposure (HR = 1.54; 95% CI 1.03–2.29) [Fn116].

The fourth point has to be read alongside the second, or a false impression results: central nervous system tumours did not reach significance in the case-control studies [Fn22], but did reach significance against CT exposure in the cohort studies [Fn116]; these are not the same result. And the exposure as defined by that review covers conventional radiography and cone-beam / medical CT [Fn117] — the exposure in the cohort-study finding is CT, and it must not be read as intraoral radiographs in general.

But the same study assigns an explicit grade to the certainty of its own evidence: thyroid cancer was rated low certainty, and central nervous system cancers very low certainty [Fn23]. The authors' conclusion is put plainly: current evidence is insufficient to confirm an association between low-dose dental radiographic exposure and cancer [Fn19]; a small increased risk was observed, but certainty remains very low, so well-designed prospective research is needed [Fn24].

How to read this passage: “an association was observed”, “statistical significance was reached” and “causation is established” are three different things. This meta-analysis gives both a significant association value and the conclusion that the evidence is insufficient to confirm an association; the two do not contradict each other, because the bias, inconsistency and imprecision of observational studies have already been counted in explicitly by GRADE [Fn23]. Any statement that cites OR = 2.21 while dropping the certainty grading has collapsed three things into one.

4-2 The cellular level: a measurable effect exists

Another 2026 systematic review and meta-analysis included 18 studies [Fn28] and analysed micronucleus formation in oral epithelial cells after exposure to dental X-rays. The pooled result showed a significant increase in micronucleus frequency after exposure (standardised mean difference = 0.30, 95% CI 0.07–0.52) [Fn30], on which the authors state that X-ray exposure induces measurable genotoxic damage in oral epithelial cells [Fn26]; although age showed only a weak correlation with micronucleus formation [Fn29]. The concluding sentence of that study also stresses that adhering to the ALARA principle, so as to reduce unnecessary radiation, is crucial [Fn27].

4-3 The honest statement that puts the two levels together

Reading 4-1 together with 4-2, the statement the literature currently supports is: the radiation from dental imaging has a measurable effect at the cellular level [Fn26]; at the population level a risk signal is observed, but certainty is low and causation is not established [Fn19][Fn24]. The authors' summary wording for the overall result is “a small increased risk” [Fn24], but that summary does not apply to every sub-result — the association between central nervous system tumours and CT exposure in the cohort studies is described in the original as moderate [Fn116], and the word “small” must not be used to paper over it when citing. Neither extreme statement therefore stands: it cannot be said that there is no biological effect, nor that carcinogenicity has been demonstrated. This is precisely why the principle of keeping dose as low as reasonably achievable exists: where the effect is not zero and the magnitude of the risk is uncertain, the right course is not to argue about whether it is safe, but to image only where there is a clinical reason, and to push each exposure down to the lowest level that remains diagnostically acceptable [Fn27][Fn32].

5. Imaging chain, part four: the framework for deciding whether to image at all

This is the link in the imaging chain that affects the patient most directly, and also the one most easily misunderstood as having a fixed timetable.

5-1 Patient selection criteria: by the patient, not by the clock

The 2026 clinical recommendations on patient selection from the American Dental Association and the American Academy of Oral and Maxillofacial Radiology (an update of the 2012 ADA/FDA guidance) were developed by an expert panel of 6 members along with an expert consultant group of 18 members [Fn6], and a systematic review of the literature was conducted to gather existing systematic reviews and organisational guidelines addressing 9 clinical questions [Fn7]. There are three core principles:

1. Clinical assessment before imaging: a thorough evaluation of the patient history and clinical findings should precede radiographic examinations [Fn1].
2. Look at existing images first: previously obtained images should be reviewed [Fn2].
3. Use judiciously, and reduce cumulative exposure: all imaging modalities, and CBCT in particular, should be used judiciously so as to reduce the patient's cumulative radiation exposure [Fn3].

Its concluding paragraph sets out the basis for the decision more clearly still: clinicians should base imaging decisions on the patient's medical and dental histories, clinical examination findings, disease risk assessment, and the presence of specific clinical conditions [Fn4].

This principle in plain terms: there is no “how often should I be X-rayed” that applies to everyone. Intervals such as half a year, one year or two years circulate online because they are easier to remember than “decided by individual risk”, but they are not what this recommendation contains.

The same recommendation is also honest about its own force: because of limitations in the available evidence, what the document developed were consensus recommendations rather than formal guidelines [Fn5]. That has to be carried along whenever it is cited. Its concluding sentence reads: when used appropriately, radiographic imaging contributes to dental treatment decisions [Fn8].

5-2 The division of labour between two radiation-protection principles

• ALARA (as low as reasonably achievable): push unnecessary radiation down to the lowest practicable level. The authors of the micronucleus meta-analysis use it as the operational recommendation of their conclusion [Fn27].
• ALADAIP: “as low as diagnostically acceptable, being indication-oriented and patient-specific” [Fn32]. This is the formulation adopted by the systematic review on dental imaging in pregnant women, and it carries two qualifiers more than ALARA — indication-oriented and patient-specific — which correspond exactly to the three principles in 5-1.

The same review contains another sentence that is often skipped and is very important: practitioners must be able to justify the examination [Fn35]. In other words, “why is this particular image being taken?” is a question that ought to have an answer.

5-3 The patient's two places in this framework

There are just two points on this chain where the patient can actually take part, but both bear directly on dose:

• Supplying existing images: previously obtained images should be reviewed [Fn2], so bringing earlier images along when changing clinic can directly reduce repeat exposures.
• Supplying history and pregnancy status: imaging decisions are based on history and clinical findings [Fn4], and imaging in pregnancy has its own separate considerations (see section 8).

6. Imaging chain, part five: the technical levers for reducing dose

A systematic review covering patients under the age of majority included 18 papers [Fn41], examined the radiation-protection measures for each class of dental imaging one by one, and states explicitly that the following radioprotective measures can reduce the exposure dose [Fn42]. Set out by type of imaging:

The same review attaches one overarching limit to these measures: all of the changes in exposure parameters should be performed while maintaining a sufficient therapeutic value on an individual and indication-based level [Fn40]. What that sentence means is that dose reduction cannot come at the cost of diagnostic value; this is a condition the original itself sets on all of the above measures, not a trade-off added by this article [Fn40].

On the CBCT side there is independent corroboration from the implant systematic review: adjusting the operating parameters and reducing the field of view to the actual region of interest can achieve significant dose reduction [Fn17].

7. Protective shielding: a consensus in the process of being rewritten

This section is where two high-level sources in this article point in different directions; both must be stated honestly, and neither may be selected over the other.

7-1 What the two sources say

Source A (2020, systematic review of radiation protection in children): among the dose-reducing measures for intraoral imaging it includes “thyroid shielding when the thyroid gland is in line of or very close to the primary beam” [Fn37]; among the measures for CBCT it likewise includes the use of a thyroid shield, with two exceptions attached (the original does not state at the abstract layer what those two situations are) [Fn120].

Source B (2023, patient shielding recommendations from the American Academy of Oral and Maxillofacial Radiology): the academy convened a task force, which reviewed monographs and reports from radiation protection organisations, and studies reporting radiation dose to the gonads, breasts and thyroid gland from dentomaxillofacial imaging [Fn47]. Its recommendation: considering the absence of radiation-induced heritable effects in humans and the negligible dose to the gonads and fetus from dentomaxillofacial imaging [Fn45], the committee recommends discontinuing shielding of the gonads, pelvic structures and fetuses during all dentomaxillofacial radiographic imaging procedures [Fn43]; and, on the basis of the radiation doses of contemporary maxillofacial imaging, it considered the risks from thyroid cancer to be negligible and recommends that thyroid shielding not be used during intraoral, panoramic, cephalometric and cone-beam computed tomographic imaging [Fn44]. The document also states that state and local authorities should be contacted to update regulations to reflect these recommendations [Fn46].

7-2 How to read this inconsistency

Neither is right and the other wrong; they answer different questions:

• Source A asks “can this measure reduce the dose that is measured?” — that is a surrogate outcome (dose), and the answer is yes [Fn37][Fn42].
• Source B asks “at contemporary dose levels, can this measure reduce risk?” — that is a judgement at the level of risk, and the answer is that the risk is already negligible, so the measure is not recommended [Fn44][Fn45].

A measure can simultaneously “reduce dose” and “no longer be recommended”: Source B's argument is that the dose to the gonads and fetus from contemporary maxillofacial imaging is negligible and that radiation-induced heritable effects have not been observed in humans [Fn45], and that the risk of thyroid cancer is likewise held to be negligible [Fn44] — under that judgement, reducing a quantity already assessed as negligible has a clinical significance that falls to negligible along with it. This article states only the conclusions of the two sources and the difference in the questions they ask; it makes no judgement as to which side is more nearly right, and states no mechanism that the sources do not contain (for example the effect of shielding on image quality or on exposure control — the source texts retrievable for this article contain nothing of the kind) — that lies beyond the evidence this article can cite.

7-3 What this means for patients in practice

• Whether or not the clinic drapes a lead apron over you has, since 2023, no longer been a reliable signal of whether that clinic takes radiation protection seriously [Fn43][Fn44].
• What really determines dose is what the previous two sections described: whether to image (the patient selection criteria [Fn4]) and how to image (collimation, receptor speed, field of view, exposure parameters [Fn37][Fn38][Fn39][Fn17]).
• The academy itself states that regulatory updating requires the involvement of the authorities [Fn46] — which means practice in different jurisdictions may be inconsistent for some time, and that falls under local regulation. Local systems and costs are covered in the corresponding canonical card (TW) and in domain article P12.

⚠ This section is a compilation of the conclusions of two professional documents; it does not constitute a recommendation as to whether protective shielding should be used for any individual patient. Actual practice follows local regulation and the dentist's judgement.

8. Imaging considerations for children and for pregnant women

These two groups are handled separately in the literature, but in different ways: for children it is “the same principles, applied more strictly”; for pregnant women it is “first dispel a misconception, then apply the same principles”.

8-1 Children

There are three citable facts about children:

1. On dose: in CBCT images, child phantoms received about 29% more effective dose than adult phantoms [Fn13].
2. On measures: the systematic review covering patients under the age of majority included 18 papers [Fn41] and summarised, one by one, the specific dose-reducing measures for each class of imaging [Fn42] (see the table in section 6).
3. On principle: all parameter adjustments must maintain sufficient therapeutic value [Fn40].

Other aspects of care in paediatric dentistry are covered in domain article P14.

8-2 Pregnant women

A systematic review devoted to dental imaging in pregnant women screened 3,913 articles and ultimately included 7 for quantitative-qualitative analysis [Fn36]. Its conclusion has three sentences, all of which must be stated together:

• Not to be restricted where clinically indicated: dental imaging examinations of pregnant women should not be restricted if clinically indicated [Fn31].
• But it must be justified, and must follow ALADAIP: practitioners must be able to justify the examination [Fn35], and must follow the radiation-protection principle of being “as low as diagnostically acceptable, being indication-oriented and patient-specific” [Fn32].
• The evidence itself is thin: few dental radiology studies have been conducted to determine the safe radiation threshold for pregnant women [Fn33]; and the reviewed articles did not provide numbers of dental examinations, by type, corresponding to this dose [Fn34].

The third sentence matters a great deal: there is at present no citable figure for an upper limit on the number of dental radiographs during pregnancy. Any statement of a specific number has no basis at the level of the existing systematic reviews.

Also to be stated alongside is Source B from section 7: it recommends discontinuing shielding of the fetus during all dentomaxillofacial radiographic imaging procedures [Fn43], on the grounds that the dose to the gonads and fetus from dentomaxillofacial imaging is negligible [Fn45].

⚠ This section is a compilation of the literature at group level; it does not constitute a recommendation for any individual pregnant woman. The complete framework for oral care in pregnancy is covered in domain article P20; whether to image must be assessed by a dentist on the individual situation.

9. Infection-control chain, part one: the overarching framework is “everyone treated alike”

This section answers the question that lies behind every infection-control question: how does a clinic know who has a transmissible disease?

The answer: it does not need to know, because the framework assumes from the outset that it does not.

9-1 Standard precautions

Standard Precautions are the foundation of all infection control programmes, and comprise “infection control practices that apply to all patients and situations regardless of whether the infection status is suspected, confirmed or unknown” [Fn48]. Two further elements were incorporated in 2007: safe injection practices, and respiratory hygiene and cough etiquette [Fn49].

The dental infection prevention and control guidelines published by the Asia Pacific Society of Infection Control in 2023 likewise place standard precautions as the minimal set of preventive measures to protect staff and prevent cross transmission [Fn52].

What this principle means directly for patients: asking “do you know whether the previous patient had hepatitis B?” is, within this framework, asking the wrong question — standard precautions are designed on the premise that this information is not available [Fn48]. What must be noted is that this does not make history-taking useless: standard precautions are a baseline that is never adjusted downwards [Fn48], while for some diseases and circumstances transmission cannot be interrupted completely with standard precautions alone [Fn51], and a further layer of transmission-based precautions is then needed on top of that baseline [Fn50] — and deciding whether to add that layer does require knowing the patient's situation. So “disclosing your history” affects whether a layer is added on top, not the baseline itself.

9-2 When standard precautions are not enough

Standard precautions are the base layer. The literature states explicitly: for some diseases and circumstances, transmission cannot be interrupted completely with standard precautions alone [Fn51], and a second layer of transmission-based precautions is then needed, in the three categories of airborne, droplet and contact [Fn50].

The Asia Pacific guidelines add two further principles bearing on clinic workflow: surgical aseptic technique is recommended when procedures are technically complex and longer in duration [Fn54]; and the design and layout of the dental facility are themselves important factors in whether infection prevention succeeds [Fn55].

9-3 What links the infection-control chain has

The 2003 dental infection control guidelines of the US Centers for Disease Control and Prevention organise this chain into a list [Fn57]. Its scope covers nine items, in the order of the original: 1) educating and protecting dental health-care personnel; 2) preventing transmission of bloodborne pathogens; 3) hand hygiene; 4) personal protective equipment [Fn57]; 5) contact dermatitis and latex hypersensitivity [Fn123]; 6) sterilisation and disinfection of patient-care items; 7) environmental infection control; 8) dental unit waterlines, biofilm and water quality [Fn58]; 9) special considerations, including dental handpieces and other devices, radiology, parenteral medications, oral surgical procedures and dental laboratories [Fn59].

Item 5 deserves to be singled out, because it is one of the few entries among the nine that bears directly on the patient rather than on personnel [Fn123]: latex hypersensitivity and contact dermatitis are material-related reactions, and their clinical management lies outside the source texts retrievable for this article. This article therefore does not expand on it and gives no instruction for recognising or handling it — but the item is on the list, and it should not be skipped over when citing.

The next five sections take, one by one, the links of this chain that bear directly on clinic workflow (item 5, as stated above, is not expanded).

⚠ The above is a compilation of the framework of international professional guidance; the regulatory requirements actually applicable in any given place follow the announcements of the local competent authority. Local systems are covered in the corresponding canonical card (TW).

10. Infection-control chain, part two: the journey of one instrument

“Has this instrument actually been disinfected?” is, professionally, not a yes-or-no question but a system of classification: different instruments are subject to different levels of processing according to the tissue they contact.

10-1 The basis of the classification

The classification system still in wide use originates in the Spaulding classification proposed in 1957. A 2023 review that screened 272 articles under a PRISMA framework records that the Spaulding classification system, originally proposed in 1957, remains widely used for defining the disinfection and sterilisation of contaminated re-usable medical devices and surgical instruments [Fn60]; and that the reason it continues to be used is that it is logical, easily applied, and readily understood by its users (microbiologists, epidemiologists, manufacturers, industry) and by regulators alike [Fn63].

In discussing whether high-risk flexible endoscopes (such as duodenoscopes) should be upgraded from semi-critical to critical, that review gives the definitions of two of the levels verbatim in square brackets: semi-critical [contact with mucous membrane and intact skin] [Fn61]; critical use [contact with sterile tissue and blood] [Fn62]. These two phrases are the original's parenthetical notes within that upgrade discussion; they are not the complete definition of the classification system — the source texts retrievable for this article do not list all the levels of the system (the Spaulding scheme has a further, lower-risk level whose definition does not appear in the text this article can cite, so this article does not state it), nor do they give the correspondence between each level and each dental instrument.

So there is only one thing this section can say: this is a classification system in which the tissue contacted determines the intensity of processing [Fn60][Fn63], rather than one process applied to every instrument. This article does not assign any individual dental instrument to any of the levels above — that review's discussion of classification takes flexible endoscopes as its example [Fn64], its abstract layer does not record the classification of dental instruments, and an item-by-item mapping would require full-text and local-regulation-level grounds, which this article states to be out of scope.

The same review is also honest about the limits of the system: substantial changes have occurred over the past 65 years (new pathogens emerging, a deeper understanding of microbial tolerance, more susceptible patients, more complex device design) that challenge the interpretation and application of this system [Fn64].

10-2 The reprocessing workflow itself has specifications

The 2025 multisociety guidance on sterilisation and high-level disinfection (endorsed by SHEA, APIC, ASGE, IDSA and SGNA [Fn68]) provides an overview of the Spaulding classification and considerations around manufacturers' instructions for use [Fn65]; the links its recommendations cover include point-of-use treatment prior to sterilisation or high-level disinfection [Fn69], monitoring for effectiveness of processing [Fn66], and tracking of reusable medical devices [Fn67].

These three links are worth singling out, because they are where the real answer to “has it been disinfected?” lies:

• Point-of-use treatment [Fn69]: what is done to the instrument between leaving the patient's mouth and entering the cleaning workflow.
• Monitoring for effectiveness [Fn66]: sterilisation is not finished the moment the button is pressed; its effectiveness has to be monitored.
• Tracking of reusable medical devices [Fn67]: being able to answer “which sterilisation batch was this instrument in?”.

The Asia Pacific guidelines add one condition about people: only trained staff are eligible to conduct reprocessing of dental instruments [Fn53].

10-3 How far this section can go

What the sources above provide is which links there should be, not the operating parameters of each link (temperature, time, criteria for cycle type). This article gives no sterilisation operating instruction; that belongs to professional training and local regulation. Local systems are covered in the corresponding canonical card (TW).

11. Infection-control chain, part three: why handpieces are singled out

The dental handpiece (the drill head) was placed under “special considerations” rather than among general instruments in the 2003 guidance framework [Fn59], because its internal structure makes reprocessing harder than for ordinary instruments.

A 2020 literature review on autoclave processing of dental handpieces gives three citable conclusions:

1. They can be sterilised, but it depends on the equipment type: dental handpieces can be sterilised, including inactivation of heat-resistant bacterial spores, with type B or type S sterilisers [Fn70].
2. Type N has its limits: when processed in a type N autoclave, complete sterilisation of the wrapped handpiece is not always achieved [Fn71].
3. Wiping is not processing: although contamination decreases with irrigation and wiping of handpieces, all the reports reached the same conclusion — these treatments alone do not achieve complete decontamination of reusable handpieces [Fn72].

The concluding sentence of that review is that understanding autoclave processing of handpieces is essential if dental practice is to deliver safe dental care [Fn73].

Point 3 is particularly useful for patients: seeing staff wipe the outside of a handpiece is part of the process, but the literature states clearly that wiping in itself does not amount to completed processing [Fn72]. This is also why section 10 lists “point-of-use treatment” and “monitoring of sterilisation effectiveness” separately [Fn69][Fn66] — they are different links.

12. Infection-control chain, part four: dental unit waterlines and biofilm

“Is the water in dentistry clean?” is the section of this article with the richest evidence, and also the one most easily misread. Two things must be kept strictly apart here: how much is detected in the environment, and how many patients are actually infected.

12-1 The environmental end: the prevalence of contamination is high

A 2023 systematic review and meta-analysis screened 736 articles and included 26 in the analysis [Fn77]. The prevalence of bacterial contamination estimated under three standards was: 85.0% (95% CI 66.0–94.0%) under the American Dental Association standard [Fn74]; and 77.0% (95% CI 66.0–85.0%) and 69.0% (95% CI 67.0–71.0%) under the US Centers for Disease Control standard and the C-100 standard respectively [Fn75]. For specific species, the prevalence of Legionella pneumophila and Pseudomonas aeruginosa was estimated at 12.0% (95% CI 10.0–14.0%) and 8.0% (95% CI 2.0–24.0%) respectively [Fn76]. The study concludes that the use of an appropriate disinfecting protocol is recommended, so as to reduce the prevalence of contamination and the probable cross-infection [Fn78].

Note first how to read this: the three figures 85%, 77% and 69% are not measuring the same thing — they are the results under three different sets of criteria [Fn74][Fn75]. Their coexistence is not a contradiction but a difference of criterion; when citing, one cannot simply pick the largest and leave the criterion out.

12-2 The risk end: the evidence of actual infection is limited

This is the other half that has to be stated alongside. A 2007 review devoted to the question of whether contaminated dental unit waterlines pose a risk of infection yields these citable conclusions:

• Route of transmission: transmission of infection from contaminated waterlines is by aerosol droplet inhalation, or more rarely by imbibing or wound contamination in susceptible individuals [Fn88].
• Pathogenicity: most of the organisms isolated from waterlines are of low pathogenicity [Fn84].
• But cases do exist: a small number of studies described infection or colonisation in susceptible hosts with Legionella spp., Pseudomonas spp. and environmental mycobacteria isolated from waterlines [Fn85].
• And one of them was a death: the same review records a case of fatal legionellosis in a dental surgeon, in which the conclusion was that the waterline was the likely source of the infection [Fn121]. This entry has to be written out — it is the record with the gravest consequence in that review, and leaving it out would make this section's “stating both sides” fail. What must be made equally clear is that the subject of that case was a member of staff (long-term, repeated exposure), not a patient attending for treatment, so it cannot be read as any probability on the patient side.
• The prevalence itself varies widely: the reported prevalence of legionellae in waterlines varies widely across the literature, from 0 to 68% [Fn86].
• In summary: although the number of published cases of infection or respiratory symptoms resulting from exposure to contaminated waterlines is limited, there remains a regulatory obligation to comply with potable water standards (the original's wording is medico-legal requirement), as well as a need to meet public expectations of water safety [Fn87].

Reading 12-1 together with 12-2, the statement the literature currently supports is: microbial contamination of dental unit waterlines is fairly widespread at the environmental level [Fn74]; most of the organisms are of low pathogenicity [Fn84]; the number of published related infection cases is limited [Fn87]; but infection or colonisation in susceptible individuals has been documented [Fn85], including one fatal case of legionellosis in a dental surgeon [Fn121]. All five clauses are needed — giving only the first few understates the need for management, while picking out only the last manufactures disproportionate fear.

12-3 The treatment end: many methods, uneven effect

A 2025 systematic review screened 8,442 articles and included 58 (published 2013–2023) [Fn79], categorising waterline disinfection methods into 14 physical and 90 chemical methods [Fn80]. Its conclusion is explicit: the effectiveness of these methods varied — for instance phenolic was effective, while alcohol was not, in reducing bacterial and biofilm contamination [Fn81]; and the review records that the effectiveness of flushing was questioned [Fn82]. The authors recommend that future studies focus on how material composition and tubing design affect biofilm development [Fn83].

[Fn82] deserves separate flagging: among this set of methods, “flushing with water” is one that is easily taken for granted as effective, and this 2025 review raised a question about its effectiveness [Fn82]. It should be said at the same time that this article states nothing about how widespread flushing is in practice, or how it is carried out — the source texts retrievable in this round contain no such data, and the sentence in the original is a clause set alongside other innovative methods, whose degree of emphasis this article has not increased. Nor does this article make any recommendation about which disinfection strategy any clinic should adopt — that belongs to the professional and regulatory domain.

⚠ This section is a compilation of group-level evidence from environmental microbiology; it does not constitute an appraisal of the water quality of any individual clinic, nor any disinfection operating instruction.

13. Infection-control chain, part five: aerosols and personal protective equipment

13-1 Aerosols are generated, and the evidence for that is sufficient

A systematic review included 80 studies (59 dental and 21 orthopaedic) [Fn91] and confirmed the generation of small particles of less than 5 μm in dental, oral and maxillofacial, and orthopaedic surgical procedures [Fn89].

13-2 But “aerosols are generated” is not “disease is transmitted”

The concluding sentence of the same review is put very carefully: there is sufficient evidence that these procedures generate an ample amount of bioaerosols, but the infectivity of these bioaerosols in transmitting diseases such as SARS-CoV-2 rests on very weak evidence [Fn90]; and the authors ask that the results of the review be interpreted with great caution [Fn92].

But “weak” is not “absent”, and this too must be stated alongside: the same review records that one study confirmed that HIV could be transmitted by aerosolised blood generated by an electric saw and bur [Fn122]. This entry is one of the 80 included studies explicitly marked as “confirmed”, and its direction does not conflict with the review's overall conclusion (that the evidence on infectivity is weak) — it is a record at the level of a single study, not a quantitative estimate of infectivity [Fn91][Fn122][Fn90]; but leaving it out would leave readers thinking that aerosol transmission had never been demonstrated for any pathogen at all.

The correct reading of this section is therefore: several layers separate “it can be detected” from “it causes disease”, and on the aerosol question that layer is explicitly marked as weak evidence by the literature itself [Fn90], while there is also one confirmed record of aerosol transmission of a bloodborne pathogen [Fn122] — both sentences hold at once, and that is exactly the distinction made in the second point of the introduction.

13-3 Measures for reducing aerosol contamination

A 2025 systematic review and meta-analysis included 19 papers [Fn93], and concludes that a multifaceted approach is needed, combining antiseptic mouthwash and suction devices, so as to reduce cross-contamination and infection transmission during aerosol-generating dental procedures [Fn94].

⚠ That study reports a pooled effect size of -46.64 (95% CI -60.89 to -32.38) [Fn95], and its heterogeneity statistic I² has the value 100 [Fn95] (that statistic is expressed as a percentage, and 100 is the top of its scale). I² sitting at the top of the scale means that heterogeneity between the included studies is extremely high, so this article takes only its directional conclusion (that multifaceted measures are needed [Fn94]) and does not use that effect size for any quantitative inference. Nor does this article give any brand, ingredient concentration or method of use for any mouthwash — the choice of mouthwash is covered in domain article P05 and in the canonical card system.

14. Infection-control chain, part six: sharps, occupational exposure and post-exposure management

The evidence in this section comes almost entirely from the personnel side, not the patient side. That qualifier has to be stated first, or the whole section will be misread.

14-1 The quantitative picture of occupational exposure

A 2022 systematic review and meta-analysis included 25 studies from 15 countries [Fn106] and estimated the pooled prevalence of needlestick and sharps injuries among dental students at 44% (95% CI 38–51%) [Fn103]; the activities carrying the highest risk were local anaesthesia, tooth cleaning or scaling, and waste disposal [Fn104]; and most studies observed under-reporting [Fn105].

A 2026 review on the dental clinical setting notes that bloodborne pathogens are transmitted from an infected source to a healthy recipient through blood or blood-contaminated media, either percutaneously or transmucosally [Fn97]; that human immunodeficiency virus, hepatitis B and hepatitis C are among the pathogens of highest concern for risk of transmission in dental practice [Fn96]; that the high global trend of occupational injuries, superimposed with under-reporting of exposures, underscores the need for advancement in prevention [Fn98]; and that enforcing clear policies on post-exposure reporting and management will enhance safety in dental settings [Fn99].

14-2 Why this concerns patients

A 2024 review records that the surgical nature of dental practice (frequent use of sharp instruments in the presence of blood) puts dental practitioners at a significant risk for infection with bloodborne pathogens, mainly hepatitis B, hepatitis C and HIV [Fn100]; and the same paper records that several seroprevalence studies and case reports traced back newly diagnosed cases of hepatitis B and C to recent episodes of dental treatment [Fn101]. That paper positions itself as offering practical advice on ways to reduce the risk of occupational exposure [Fn102].

[Fn101] is one of the few citations in this article that directly connects “dental treatment” with “newly diagnosed infection on the patient side”. Its form is seroprevalence studies and case reports, not a quantitative estimate of incidence — so it can support “this risk is not zero, and that is why the protective chain exists”, but it cannot support any figure for probability [Fn101].

14-3 What this section must not be turned into

• 44% [Fn103] cannot be read as a patient risk — the population behind that figure is dental students [Fn106].
• [Fn101] cannot be read as an incidence — its study form does not support that.
• Sharps safety and post-exposure management are internal clinic processes; this article provides no operational content on them.

15. How to read the evidence on “will I catch something?”

This is a question asked very often in this field, and a hard one to answer with a figure. At present there is just one citable quantitative reference point, and it has to be cited together with its study design.

15-1 The sole quantitative reference point available at present, and what it actually means

A 2022 meta-analysis included 71 studies [Fn109], divided invasive procedures into 10 categories, and calculated the pooled odds ratio for the association of each with hepatitis C virus infection. The result: the pooled odds ratios varied widely, ranging from 1.46 (95% CI 1.14–1.88) for dental procedures to 3.22 (1.7–6.11) for transplantation [Fn107]. The study's background statement is that healthcare settings where invasive procedures are frequently performed may play an important role in the transmission dynamics of bloodborne pathogens when compliance with infection control precautions is suboptimal [Fn108]; and its stated purpose is to provide a ranking of procedures by risk, for use in prioritising infection control interventions [Fn110].

Three things this figure must never be read as:

1. Not “the probability of catching hepatitis C at the dentist is 1.46%” — an odds ratio is not a percentage; mathematically the two are different quantities.
2. Not an epidemiological figure for dental clinics — the aim of that analysis was to understand and quantify the role of hospital-based invasive procedures in HCV transmission [Fn126], and it is a comparison across categories [Fn109].
3. Not a fixed value that can be extrapolated to any setting — the analysis included 71 studies [Fn109] spanning different countries and contexts; the original used meta-regression to test the relationship between the pooled estimates and country-level HCV prevalence and the Healthcare Access and Quality (HAQ) index [Fn124], and in the procedure-specific analysis the moderating relationships that reached significance were for endoscopy and surgery, not for dental procedures [Fn125].

A misreading that is easy to make has to be corrected here (an earlier version of this article made it too): the background sentence of that study reads that healthcare settings where invasive procedures are frequently performed may play an important role in the transmission dynamics of bloodborne pathogens when compliance with infection control precautions is suboptimal [Fn108] — that is the study's framing and motivation, not a condition on which this pooled odds ratio holds. The abstract layer records no subgroup results stratified by compliance, so 1.46 cannot be described as “describing only the situation in which the protective chain has failed”; such a statement would be an unsourced downgrade. It is simply the pooled result of 71 studies, and its limits are set out in points 1, 2 and 3 above [Fn109][Fn107].

The one thing it can be read as: among the 10 categories of invasive procedure compared in that analysis, the pooled odds ratio for dental procedures falls at the lower end of the range (1.46 against 3.22 for transplantation) [Fn107].

15-2 Why there is no better figure

This round of searching retrieved no systematic review or meta-analysis with “incidence of infection in patients at dental clinics” as its outcome. What the literature can currently give is a combination of three kinds of surrogate evidence:

• the prevalence of contamination at the environmental end (section 12) [Fn74];
• the prevalence of occupational exposure at the personnel end (section 14) [Fn103];
• the relative risk positioning across procedure categories (this section) [Fn107].

None of the three is an incidence of infection on the patient side. This is an evidence gap stated honestly; any claim to know “what the probability of catching something at a dental clinic is” has no basis at the current level of the literature.

15-3 So where does the framework return to

Back to section 9: because it is impossible to know in advance who carries what pathogen, standard precautions are designed to apply alike to all patients [Fn48]; and where standard precautions are not sufficient to interrupt transmission, transmission-based precautions are added on top [Fn50][Fn51]. The value of this framework is not that it can produce a reassuring figure, but that it does not depend on anyone knowing the answer in advance.

16. What the cost of safe practice is made of (no amounts of any kind)

This section describes only the components and drivers of cost; it provides no amounts, fees or reimbursement information.

The cost structure around in-clinic safety can be worked back from the technical requirements set out in the preceding sections:

• Grade of sterilisation equipment: the literature indicates that sterilisation effectiveness for handpieces is directly related to the type of steriliser (type B, type S, type N) [Fn70][Fn71], so equipment grade is a structural cost driver.
• Staffing and training for reprocessing: only trained staff are eligible to carry out instrument reprocessing [Fn53], so training and staffing are a continuing cost.
• Monitoring and tracking: monitoring of sterilisation effectiveness [Fn66] and tracking of instruments [Fn67] are separate links listed in the guidance, each requiring its own investment.
• Waterline management: the literature summarises as many as 14 physical and 90 chemical waterline disinfection methods, of uneven effect [Fn80][Fn81]; management strategy and monitoring frequency affect consumable and staffing costs.
• Single-use items and barriers: personal protective equipment, environmental barriers and disposable items are a separate dimension of infection-control compliance [Fn112].
• Imaging equipment and parameters: the differences in dose between CBCT devices arise from device and settings [Fn16][Fn17], while the dose-reducing measures (collimation, receptor speed, automatic exposure control) are themselves configurations at equipment and consumable level [Fn37][Fn38].
• Facility design: the design and layout of the dental facility are listed as important factors in whether infection prevention succeeds [Fn55], and represent a one-off capital investment.

Local systems and costs are covered in the corresponding canonical card (TW) and in domain article P12. Fee regulations, reimbursement scope and regulatory requirements differ enormously between jurisdictions, and are outside the scope of this article.

17. What patients can observe — and the limits of those observations

The conclusion first: the diagnostic value of observable cues is limited, and this section is not an appraisal tool.

17-1 The nine focus areas the professional standard examines

A systematic review examined compliance with infection control in oral health-care facilities worldwide, and its survey covered nine focus areas [Fn111], item by item: ① knowledge of infectious occupational hazards; ② personal hygiene and care of hands; ③ correct application of personal protective equipment; ④ use of environmental barriers and disposable items [Fn112]; ⑤ sterilisation (recirculation) of instruments and handpieces; ⑥ disinfection of surfaces and housekeeping; ⑦ management of waste disposal; ⑧ quality control of dental unit waterlines, biofilms and water [Fn113]; ⑨ and some special considerations [Fn118] (the original does not enumerate the content of item ⑨ at the abstract layer, so this article does not supply its details). The review also notes that practice varies widely between countries, but that the principles of infection prevention and control are the same globally [Fn114].

17-2 Which of these nine areas are visible in the clinic

Setting those nine areas against what a patient can actually see (the nine rows below are items ① to ⑨ of 17-1, with no items from other sources mixed in):

(One further factor, not among the nine areas above but likewise at the environmental level: the design and layout of the dental facility are listed as important factors in whether infection prevention succeeds [Fn55], and its circulation and spatial arrangement are partly visible to patients. This entry comes from a different source and is therefore not counted among the nine areas.)

The key to this table is the “not visible” rows: the links where risk in this field is concentrated (sterilisation effectiveness [Fn66], water quality [Fn74], staff training [Fn53]) happen to be exactly those that cannot be judged by eye. Therefore:

• visible cues are not sufficient to determine safety;
• not seeing an action does not mean that link has not been performed.

17-3 Two things patients can do that the literature supports

• Take part at the imaging end: supplying existing images [Fn2] and a complete history [Fn4] bears directly on whether an image is needed and on what image is taken.
• Understand what may reasonably be asked: since practitioners must be able to justify the examination [Fn35], “what is this radiograph meant to show?” is itself a reasonable question within the framework.

17-4 What not to use it for

The Asia Pacific guidelines come with a checklist to help facilities identify gaps for improvement [Fn56]; that is a quality-improvement tool for institutions, not an appraisal scale for patients. This article provides no list that could be used to evaluate any individual practice, and makes no judgement about the practice of any institution. The same systematic review also records that the availability of resources poses different challenges in different regions, and that studies in developing countries indicate serious shortcomings in infection prevention and control knowledge and education [Fn115] — this is a structural description at regional level, and must not be extrapolated into an inference about any specific institution.

18. Risk factors (indications / adverse effects / contraindications and limits)

Indications

• Imaging examinations: imaging decisions should be based on the patient's medical and dental histories, clinical examination findings, disease risk assessment, and the presence of specific clinical conditions [Fn4]; a thorough evaluation of the patient history and clinical findings should precede radiographic examinations [Fn1]. When used appropriately, radiographic imaging contributes to dental treatment decisions [Fn8].
• Imaging in pregnancy: should not be restricted where clinically indicated [Fn31].
• CBCT: the literature records that its indications in implant dentistry cover preoperative anatomical assessment, planning of site reconstruction, computer-aided treatment planning and assessment of postoperative complications [Fn18]; at the same time it should be used judiciously, so as to reduce cumulative exposure [Fn3].
• Standard precautions: apply to all patients and all situations, whether the infection status is suspected, confirmed or unknown [Fn48].
• Surgical aseptic technique: recommended for procedures that are technically complex and longer in duration [Fn54].

Possible adverse effects and outcomes

• Cellular-level effect of radiation: X-ray exposure induces measurable genotoxic damage in oral epithelial cells (standardised mean difference 0.30, 95% CI 0.07–0.52) [Fn26][Fn30].
• Population-level association of radiation: in case-control studies thyroid cancer was significantly associated with dental imaging (OR 2.21) [Fn21], while central nervous system tumours did not reach significance (OR 1.31) [Fn22]; in cohort studies thyroid cancer showed a small but significant association with conventional radiography (HR 1.13) [Fn25], and the risk of central nervous system tumours was moderately associated with CT exposure (HR 1.54; 95% CI 1.03–2.29) [Fn116]; the exposure definition of that review covers conventional radiography and cone-beam / medical CT [Fn117]. However, the certainty of the evidence was rated low to very low under GRADE [Fn23], and the authors' conclusion is that the evidence is insufficient to confirm an association [Fn19].
• Higher dose in children: in CBCT, child phantoms received about 29% more effective dose than adult phantoms [Fn13].
• A larger field of view raises dose: the effective dose of a large field of view was about 1.6 times that of a small one [Fn14].
• Waterline microorganisms: the prevalence of bacterial contamination of dental unit waterlines is high [Fn74]; infection or colonisation in susceptible hosts has been documented [Fn85]; the route of transmission is aerosol droplet inhalation, or more rarely imbibing and wound contamination [Fn88].
• Bloodborne pathogens: HIV, hepatitis B and hepatitis C are among the pathogens of highest concern for risk of transmission in dental practice [Fn96]; seroprevalence studies and case reports have traced newly diagnosed hepatitis B and C back to recent dental treatment [Fn101].
• Occupational sharps injuries: the pooled prevalence of needlestick and sharps injuries among dental students is 44% (95% CI 38–51%) [Fn103], and most studies observed under-reporting [Fn105].

Contraindications and limits of applicability

• Limits on imaging: all adjustments of exposure parameters must maintain sufficient therapeutic value on an individual and indication-based level [Fn40] — dose reduction must not come at the cost of diagnostic value. Practitioners must be able to justify the examination [Fn35].
• Regional differences in the shielding recommendations: the American Academy of Oral and Maxillofacial Radiology recommends discontinuing shielding of the gonads, pelvic structures and fetuses [Fn43], and recommends that thyroid shielding not be used [Fn44]; it also states that state and local authorities need to update regulations to reflect these recommendations [Fn46] — actual practice follows local regulation and must not be extrapolated at will.
• Ceiling of the evidence (radiation risk): the certainty of evidence in the cancer-risk meta-analysis is low to very low [Fn23], and the authors call for well-designed prospective research [Fn24]; in the micronucleus study the relationship with age remains inconclusive [Fn29].
• Ceiling of the evidence (pregnancy): few dental radiology studies have been conducted to determine the safe radiation threshold for pregnant women [Fn33], and the reviewed articles did not provide numbers of examinations, by type, corresponding to that dose [Fn34] — there is at present no citable upper limit on the number of radiographs during pregnancy.
• Ceiling of the evidence (dose figures): the dose figures cited in this article come from a compilation of literature published between 2010 and 2020 [Fn15], include phantom simulation results, and have wide ranges for each examination [Fn9][Fn10][Fn11]; the spread between CBCT devices reaches about a hundredfold [Fn16]. For magnitude reference only; not to be used for individual prediction.
• Ceiling of the evidence (waterlines): three sets of criteria give three different prevalence figures [Fn74][Fn75]; the prevalence of legionellae ranges across studies from 0 to 68% [Fn86]; the number of published related infection cases is limited [Fn87]; and the effectiveness of flushing has been questioned [Fn82].
• Ceiling of the evidence (aerosols): bioaerosols are indeed generated [Fn89][Fn90], but the evidence for their infectivity in transmitting disease is very weak, and the authors ask for great caution in interpretation [Fn90][Fn92]; the same review also records one confirmed study of aerosolised blood transmitting HIV [Fn122], which is a record at single-study level rather than a quantitative estimate of infectivity; and in the aerosol-control meta-analysis the heterogeneity statistic I² sits at the top of its scale (value 100) [Fn95], so this article does not adopt its effect size.
• Ceiling of the evidence (quantifying infection risk): the sole cross-procedure reference point available at present is an odds ratio of 1.46 (95% CI 1.14–1.88) [Fn107], whose target setting is hospital-based invasive procedures [Fn126] and which is a comparison across categories [Fn109]; the original used meta-regression to test the relationship with country-level HCV prevalence and the HAQ index [Fn124], and in the procedure-specific analysis those reaching significance were endoscopy and surgery rather than dental procedures [Fn125]. An odds ratio is not an incidence and must not be converted into a percentage; the background statement of the original (the role in transmission when compliance with infection control is suboptimal [Fn108]) is the study's motivation, and must not be written as a condition on which that pooled estimate holds.
• Limits of population representativeness: the population behind the occupational exposure figures is dental students [Fn106], which does not represent patient risk; the description of regional differences in the infection-control compliance review is a structural description [Fn115], and must not be extrapolated to any specific institution.
• Limits on the force of the guidance: because of limitations in the available evidence, what the patient-selection recommendations developed were consensus recommendations rather than formal guidelines [Fn5]; and the Spaulding classification system itself is noted to face challenges of interpretation and application [Fn64].
• This article contains no operating instruction of any kind: the citations touching on sterilisation, disinfection, waterline treatment, aerosol control and sharps handling are all either guidance frameworks or group-level research conclusions, and constitute no operational teaching; the citations touching on mouthwash present research-level conclusions only, and involve no brand, ingredient concentration or method of use.

⚠ This section is a disclosure of medical risk and does not constitute advice on any individual course of care. Actual treatment and its effect vary from person to person and must be assessed by a dentist.

Every clinical statement in this article is mapped line by line to its cited source (see the sources and evidence chain below). It has not been clinically reviewed by a licensed practitioner. This is health information, not individual advice; assessment by a clinician is required.